Shuttle Pharmaceuticals Holdings (SHPH) EPS (Weighted Average and Diluted) (2022 - 2026)

Shuttle Pharmaceuticals Holdings' EPS (Weighted Average and Diluted) history runs 5 years deep, the most recent figure standing at -$0.43 for Q1 2026.

• In Q1 2026, EPS (Weighted Average and Diluted) rose 94.34% year-over-year to -$0.43; the TTM figure through Mar 2026 stood at -$4.71 (up 93.06% YoY), while the FY2025 annual figure was -$7.16, up 91.33% from the prior year.
• EPS (Weighted Average and Diluted) was -$0.43 for Q1 2026 at Shuttle Pharmaceuticals Holdings, down from $0.06 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $3.7 in Q4 2024 to a low of -$39.83 in Q3 2024.
• Historically, EPS (Weighted Average and Diluted) has averaged -$5.12 across 5 years, with a median of -$0.87 in 2023.
• Biggest YoY gain for EPS (Weighted Average and Diluted) was 556.79% in 2024; the steepest drop was 4276.92% in 2024.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$4.81 in 2022, then soared by 83.16% to -$0.81 in 2023, then soared by 556.79% to $3.7 in 2024, then tumbled by 98.38% to $0.06 in 2025, then tumbled by 816.67% to -$0.43 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at -$0.43 (Q1 2026), $0.06 (Q4 2025), and -$1.05 (Q3 2025), per Business Quant data.